PACS Group, Inc. (PACS): A Bull Case Theory
We came across a bullish thesis on PACS Group, Inc. on wallstreetbets subreddit by Simple-Software3. In this article, we will summarize the bulls’ thesis on PACS.
Pacs Group Inc. (PACS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Royce & Associates Chuck Royce | 1,859,070 | $25,525,031 | +77% | 0.25% |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,010,906 | $13,879,739 | +349% | 0.01% |
| 3. | Renaissance Technologies Jim Simons | 89,800 | $1,232,954 | -14% | 0% |
| 4. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 26,977 | $370,394 | -41% | 0% |
| 5. | Greenland Capital Management Michael Englander | 26,000 | $356,980 | -10% | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $23.08 | 433 | $9,992.73 | 433 | 2024-04-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $36.25 | 8,128,352 | $294,652,760.00 | 45,126,199 | 2024-09-09 | Filing | |
| $36.25 | 8,128,352 | $294,652,760.00 | 45,126,199 | 2024-09-09 | Filing | |
| $21.00 | 1,607,142 | $33,749,982.00 | 62,754,551 | 2024-04-15 | Filing | |
| $21.00 | 1,607,142 | $33,749,982.00 | 62,754,551 | 2024-04-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,057,648 | $69,441,505 | 0% | |
| 2. | 4,950,800 | $67,974,488 | 0% | |
| 3. | 3,939,725 | $54,092,425 | 0% | |
| 4. | 1,112,068 | $15,268,694 | 1.46% | |
| 5. | 996,555 | $13,684,394 | 0% |
News See All
PACS Group, Inc. (PACS) Gains NYSE Extension Amid Financial Restatements, Projects Record H1 Revenue
PACS Group, Inc. (NYSE:PACS), a leading post-acute care provider, has been in focus this September amid regulatory challenges and operational growth.
12 Healthcare Stocks with Insider Buying in 2025
In 2025, there will be a complicated combination of opportunities and difficulties in the healthcare innovation landscape, with divergent trends in technology adoption, investment, and fundraising.
PACS Group (PACS): A Bull Case Theory
We came across a bullish thesis on PACS Group on wallstreetbets's Substack. As of 28ᵗʰ August, PACS Group's share was trading at $11.61.
10 Best Small-Cap Stocks to Buy Before They Explode
Since the announcement of tariffs, investors have been concerned regarding the market volatility.
10 Best Small-Cap Value Stocks to Buy Now
Earlier on February 24, Robert Teeter of Silvercrest Asset Management shared his perspective on small-cap stocks and highlighted their link to economic conditions and sensitivity to financing activity...
Here’s Why Wasatch Small Cap Growth Strategy Sold PACS Group (PACS)
Wasatch Global Investors, an asset management company, released its “Wasatch Small Cap Growth Strategy” fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Worst Performing Mid Cap Stocks to Buy According to Analysts
Market analysts are increasingly highlighting mid-cap stocks as a potentially attractive investment opportunity, particularly in the current economic climate.
12 Stocks That Will Double in 2025
A lot is happening in the market, especially within the growth sectors.
10 Cheap New Stocks To Buy Right Now
The US IPO market experienced a rebound in 2024, with proceeds and deal volume increasing as compared to the previous two years.